Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy

Misghina Weldegiorgis; Dick de Zeeuw; Liang Li; Hans‐Henrik Parving; Fan Fan Hou; Giuseppe Remuzzi; Tom Greene; Hiddo J.L. Heerspink

doi:10.1053/j.ajkd.2017.08.010

Related publications

Article2002

Nephropathy in Patients with Type 2 Diabetes

Giuseppe Remuzzi, Arrigo Schieppati, Piero Ruggenenti

Article2021

Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial

Fabiola Carrara, Piero Ruggenenti, Annalisa Perna, Ilian Iliev, Flavio Gaspari, Silvia Ferrari, Nadia Stucchi, Antonio Bossi, Roberto Trevisan, Giuseppe Remuzzi, Aneliya Parvanova

Article2013

The GFR and GFR decline cannot be accurately estimated in type 2 diabetics

Flavio Gaspari, Piero Ruggenenti, Esteban Porrini, Nicola Motterlini, Antonio Cannatà, Fabiola Carrara, Alejandro Jiménez, Claudia Cella, Silvia Ferrari, Nadia Stucchi, Aneliya Parvanova, Ilian Iliev, Roberto Trevisan, Antonio Bossi, Jelka Zaletel, Giuseppe Remuzzi

Article2006

Risk Scores for Predicting Outcomes in Patients with Type 2 Diabetes and Nephropathy

William F. Keane, Zhongxin Zhang, Paulette A. Lyle, Mark E. Cooper, Dick de Zeeuw, Jean-Pierre Grunfeld, James P. Lash, Janet B. McGill, William E. Mitch, Giuseppe Remuzzi, Shahnaz Shahinfar, Steven Snapinn, Robert D. Toto, Barry M. Brenner

Article2016

The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy

Michelle J. Pena, Dick de Zeeuw, Dennis L. Andress, John J. Brennan, Ricardo Correa‐Rotter, Blai Coll, Donald E. Kohan, Hirofumi Makino, Vlado Perkovic, Giuseppe Remuzzi, Sheldon W. Tobe, Robert D. Toto, Hans‐Henrik Parving, Shoba Sharma, Tom Corringham, Kumar Sharma, Hiddo J.L. Heerspink